Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.53 USD | +2.69% | -3.74% | 0.00% |
Apr. 22 | Guggenheim Starts Coverage on Boundless Bio With Buy Rating, $24 Price Target | MT |
Apr. 22 | Piper Sandler Starts Audentes Therapeutics With Overweight Rating, $20 Price Target | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 212M |
---|---|---|---|---|---|
Net income 2024 * | -68M | Net income 2025 * | -94M | EV / Sales 2024 * | - |
Net cash position 2024 * | 30.75M | Net cash position 2025 * | 36.28M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-2.84
x | P/E ratio 2025 * |
-2.56
x | Employees | 72 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.54% |
1 day | +2.69% | ||
1 week | -3.74% | ||
Current month | -3.74% | ||
1 month | -11.68% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-15 | 9.53 | +2.69% | 109,866 |
24-05-14 | 9.28 | -2.52% | 76,756 |
24-05-13 | 9.52 | +10.83% | 79,909 |
24-05-10 | 8.59 | -5.60% | 56,008 |
24-05-09 | 9.1 | -8.08% | 95,677 |
Delayed Quote Nasdaq, May 15, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
0.00% | 212M | |
+7.52% | 113B | |
+11.38% | 106B | |
-12.64% | 22.22B | |
+0.44% | 22.27B | |
-4.18% | 19.43B | |
-37.85% | 17.87B | |
-8.58% | 17.24B | |
+37.41% | 12.52B | |
-23.95% | 8.34B |
- Stock Market
- Equities
- BOLD Stock